NextGen Healthcare, Inc. (NXGN): Price and Financial Metrics
NextGen Healthcare, Inc. (NXGN)
Today's Latest Price: $21.17 USD
Updated Jan 15 4:00pm
Add NXGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
NXGN Stock Summary
- With a price/earnings ratio of 147.16, Nextgen Healthcare Inc P/E ratio is greater than that of about 93.94% of stocks in our set with positive earnings.
- For NXGN, its debt to operating expenses ratio is greater than that reported by 26.74% of US equities we're observing.
- With a year-over-year growth in debt of 116.1%, Nextgen Healthcare Inc's debt growth rate surpasses 89.68% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Nextgen Healthcare Inc are NOVT, LMNX, VIAV, ATEN, and RDWR.
- Visit NXGN's SEC page to see the company's official filings. To visit the company's web site, go to www.nextgen.com.
NXGN Stock Price Chart Interactive Chart >
NXGN Price/Volume Stats
| Current price | $21.17 | 52-week high | $22.46 |
| Prev. close | $21.62 | 52-week low | $5.10 |
| Day low | $20.56 | Volume | 242,200 |
| Day high | $22.00 | Avg. volume | 272,670 |
| 50-day MA | $17.74 | Dividend yield | N/A |
| 200-day MA | $13.39 | Market Cap | 1.41B |
NextGen Healthcare, Inc. (NXGN) Company Bio
NextGen Healthcare (formerly Quality Systems) develops and markets computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. The company was founded in 1974 and is based in Irvine, California.
NXGN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $21.17 | $7.97 | -62% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Nextgen Healthcare Inc. To summarize, we found that Nextgen Healthcare Inc ranked in the 29th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for NXGN, they are:
- In the past 5.42 years, Nextgen Healthcare Inc has a compound free cash flow growth rate of 0.02%; that's better than only 18.5% of cash flow producing equities in the Technology sector, where it is classified.
- The business' balance sheet reveals debt to be 7% of the company's capital (with equity being the remaining amount). Approximately just 21.61% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- Nextgen Healthcare Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -63% |
| 1% | -63% |
| 2% | -62% |
| 3% | -62% |
| 4% | -62% |
| 5% | -61% |
Want more companies with a valuation profile/forecast similar to that of Nextgen Healthcare Inc? See EEFT, NVDA, SGMA, BKI, and COHR.
Loading social stream, please wait...